CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
repetitive Transcranial Magnetic Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05488808
NCT05488808N/ACompleted

Deep Repetitive Transcranial Magnetic Stimulation for Peripheral Neuropathic Pain. A Randomized Double-blind Sham-controlled Study.

Oslo University Hospital·interventional·Posted Aug 5, 2022·Updated Nov 27, 2023

In Brief

A clinical study evaluating repetitive Transcranial Magnetic Stimulation for Neuropathic Pain. Completed, enrolled 17 participants across 1 site.

Detailed Summary

Peripheral neuropathic pain is a disabling chronic pain condition that is difficult to treat. Repetitive transcranial magnetic stimulation (rTMS) to the motor cortex is a treatment method with growing evidence in its ability to alleviate neuropathic pain. This also applies to new deep rTMS coils which permits stimulation of larger cortical areas and with deeper penetration. The aim of this study is to investigate the analgesic efficacy of 5 days of deep rTMS compared to sham stimulation. We will also assess effects of deep rTMS on sleep, psychological fatctors, everyday functioning, and executive functioning.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesNorway
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 5, 2022
Enrollment StartFeb 1, 2022
Primary CompletionNov 24, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 3.9 years ago

Interventions

repetitive Transcranial Magnetic Stimulationdevice

Deep rTMS is delivered with the Brainsway H7-coil (Brainsway, Jerusalem, Israel) applied via a helmet placed on the head targeting the primary motor cortex of the leg.